Oncology / Applications

Setting the new standard 
for cancer diagnostics

Background image

With Geno1® Bridge Capture™, targeted sequencing is effortless. Power up your oncological assays with industry-leading sensitivity, affordability, and scalability.

  • Affordable testing

    Bridge Capture™ is engineered for cost-efficiency, utilizing off-the-shelf reagents and optimizing the use of sequencing capacity to minimize test costs.

  • Sensitive detection

    Bridge Capture™ delivers proven sensitivity, meeting the rigorous demands of even the most challenging oncological applications.

  • Portable workflows

    Bridge Capture™ is designed for simplicity, portability, and kittability, ensuring seamless adoption in any laboratory setting, effortless usability in distributed environments, and compatibility with any sequencing platform.

  • Pan-cancer detection

    Bridge Capture™ supports panels of any size, enabling true pan-cancer detection across any number and type of mutations.

Applications

  • 01
    Treatment selection

    Using Genomill’s pan-cancer panel, detect up to 23’000 mutations relevant for finding the right treatment for cancer.

  • 02
    Minimal residual disease detection

    Tumor-naive tool for monitoring cancer recurrence. Powered by Genomill’s pan-cancer panel consisting of 23’000 relevant mutations.

  • 03
    Early detection

    Highly sensitive cancer-agnostic tool for detecting the first mutational signatures of an emerging tumor. Powered by Genomill’s pan-cancer panel consisting of 23’000 relevant mutations.

  • Read more about the technology

BRIDGE CAPTURE™

FAQ

See all FAQ

BRIDGE CAPTURE™

Panel FAQ